BriaCell Therapeutics Corp (BCTXW) — Cash Flow Reinvestment Rate
BriaCell Therapeutics Corp (BCTXW) has a Cash Flow Reinvestment Rate of 0.00x as of April 2020, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $60.39K. Check BCTXW cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
BriaCell Therapeutics Corp Cash Flow Reinvestment Rate (2006–2006)
Historical reinvestment intensity for BriaCell Therapeutics Corp across 1 annual periods. Explore BriaCell Therapeutics Corp strategic investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for BriaCell Therapeutics Corp (2006–2006)
Year-by-year capital reinvestment analysis for BriaCell Therapeutics Corp. For live market cap and broader valuation context, see BriaCell Therapeutics Corp stock valuation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2006 | 0.00x | $0.00 | $1.13K | $0.00 | — |